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Abstract  
The term dependency is increasingly being used also to explain symptoms 
resulting from the repetition of a behavior or legalized and socially 
accepted activities that do not involve substance assumption. These 
activities, although considered normal habits of daily life can become real 
addictions that may affect and disrupt socio-relational and working 
functioning. Growing evidence suggests to consider behavioral addictions 
similar to drug dependence for their common symptoms, the high 
frequency of poly-dependence conditions, and the correlation in risk 
(impulsivity, sensation seeking, early exposure, familiarity) and protective 
(parental control, adequate metacognitive skills) factors.  
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The aim of this paper is to describe addiction in its general aspects, 
highlighting the underlying neurobiological and psychopathological 
mechanisms. 
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Introduction  
The World Health Organization (WHO) defines the dependence syndrome 
as "A state, psychic and sometimes also physical, resulting from the 
interaction between a living organism and a drug, characterized by 
behavioral and other responses that always include a compulsion to take 
the drug on a continuous or periodic basis in order to experience its 
psychic effects, and sometimes to avoid the discomfort of its absence." 
(Pigatto, 2003). 
Similarly, the Diagnostic and Statistical Manual of Mental Disorders 
DSM-IV-TR (APA, 2000) and the International Statistical Classification of 
Diseases and Related Health Problems (ICD-10, WHO, 1993) introduced 
the term "dependence" with reference only to psychoactive substances, 
highlighting cognitive, behavioral and physiological symptoms due to 
misuse. Beyond the above meaning, which is largely shared in scientific 
literature and in clinical practice, the term dependency is increasingly 
being used also to explain symptoms resulting from the repetition of a 
behavior or legalized and socially accepted activities that do not involve 
substance assumption (Shaffer & Kidman, 2003). These activities, 
although considered normal habits of daily life, can become real addictions 
that may affect and disrupt socio-relational and occupational functioning. 
Growing evidence suggests that behavioral and substance addictions share 
phenomenical similarities: the inability to resist an impulse or the 
temptation to perform an act (compulsion); tension or arousal before 
committing the act (craving); pleasure, gratification or relief at the time of 
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committing the act; feeling of loss of control; persistence of the behavior 
despite the negative consequences.  
To date, no consensus exists about a univocal, shared classification of such 
conditions that are usually encompassed under the generic term of New 
Addictions (Ferrini & Rontini, 2011), a definition that generically highlight 
a problematic behavior.  
Dependence has also been defined on the basis of social rules, where social 
dependencies regard legal drugs (tobacco, alcohol, medications), and 
socially accepted activities, such as eating, working, shopping, play, 
browsing the web. Antisocial dependencies include psychoactive drug use 
and illegal activities (Alonso Fernandez, 1999). This classification 
highlights the social and cultural nature of dependencies, suggesting that 
the differences between Substance Use Disorder (SUD) and New 
Addiction lies in the different focus of addiction. It also should be 
highlighted the difference between the concepts of Dependence and 
Addiction, where the first term refers to the physical and chemical 
dependency, a condition in which the body needs a substance to function, 
and the second defines a general condition in which there is an unhealthily 
strong motivation to engage in a particular behavior, usually driven by 
physiological, psychological, environmental and social factors. 
Dependence and Addiction, however, does not necessarily occur together. 
Evidence suggests considering the behavioral addictions similar to drug 
dependence, due to the common symptoms, the high frequency of poly-
dependence conditions, and the correlation in risk (impulsivity, sensation 
seeking, early exposure, familiarity) and protective (parental control, 
adequate metacognitive skills) factors (Alavi et al., 2012). According to 
these findings, many authors postulate the existence of a real dependence 
syndrome or “Pathology addiction” (Orford, 2001) caused by the repetition 
of any conduct which produces short-term reward that may engender 
persistent behavior for reducing negative affective states and to enhance 
the positive ones. 
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The natural evolution of this perspective is not only to admit that several 
compulsive behaviors, such as gambling, are real addictions comparable to 
drug addiction, but also to hypothesize the existence of a single addiction 
syndrome with different expressions. Viewing addiction as a syndrome has 
several implications for research and treatment (Shaffer et al., 2004). Some 
authors (Blaszczynski, 1999) take position against the concept of addiction 
without substance, considering behavioral addictions such as compulsions 
or elements of the Obsessive-Compulsive Spectrum disorders. Thus, it 
seems important to highlight the similarities and differences between the 
two conditions (Alonso Fernandez, 1999): if both disorders are 
characterized by uncontrolled and inevitable behaviors, they differ in the 
egosyntonic/egodystonic dimension. Reflection is low or absent in 
impulse/urge, and excessive in compulsion; dependence involves loss of 
control, whereas the obsessive-compulsive spectrum is characterized by 
the reduction of the decisional processes. It has been shown that 
pathological gamblers also express compulsive and obsessive traits, 
including excessive worry for intrusive thoughts and difficulty in decisions 
making (Blaszczynski, 1999). However, despite these findings, the 
symptoms of the new addictions are better classified into the dimension of 
impulsivity, rather than into the obsessive-compulsive spectrum disorders. 
Consequently, the definition of "dependent" may apply to those individuals 
whose existence is devoted to hunt for the effects of a substance (legal, 
prohibited, or prescribed drug) or a behavior (playing, browsing the web, 
sex or compulsive shopping) with intense physical and/or psychological 
discomfort (Valleur & Matysiak, 2003). Within this context, for the 
addicted there is nothing else that matters, and the socio-emotional 
disinvestment is pervasive. Actually, we can assume that such conducts lie 
at an extreme pole along a continuum of behaviors that gradually run from 
normality to pathology (Blaszczynski et al., 2004; Lavanco, 2004).  
 
 
Congruently with this shift in theoretical perspective, in the fifth edition of 
the Diagnostic and Statistical Manual of Mental Disorders - DSM 5, the 
Substance Use Disorder (SUD) section has undergone substantial changes, 
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including the replacement of abuse and dependence categories with a 
single construct, the "Substance-related and Addictive Disorders" section. 
Beyond substance-related disorders, the section also includes Gambling 
Disorder (GD), classified in the previous editions within the Impulse 
Control Disorder section, whereas Internet Disorder has included in the 
appendix as a condition that requires further research (APA, 2013).  
There is strong evidence suggesting that GD and SUD share several 
common features that go far beyond behavioral characteristics, as 
demonstrated by neurobiological and neuroimaging studies showing a 
substantial overlap between the two disorders (Kober et al., 2016).  
The aim of this paper is to describe addiction-like behaviors, highlighting 
the underlying neurobiological and psychopathological mechanisms. 
Neurobiolgy 
It is well known that at the basis of addiction there is an alteration of those 
brain mechanisms which control the reward system and motivational 
states, as well as other functional systems involved in learning and 
memory. These systems are interconnected at various levels, from genetic 
regulation of neurotransmitters synthesis to the affective and cognitive 
processing of internal urges and external stimuli. From a neurobiological 
point of view there are not substantial differences between drug and 
behavioral addictions: a gratification is anyway a gratification, regardless 
of whether it is induced by a substance, experience or relationship (Brewer 
& Potenza, 2008), and, where is a gratification, it is possible that a 
vulnerable individual is caught into an addiction. What seems important is 
the high frequency of repetition of highly rewarding activities, which 
parasite those neural circuits evolved to sustain reward activities related to 
the survival (Potenza, 2006). 
 
The motivation and reward system 
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The reward system allows us to experience a series of physical and 
emotional sensations that we consciously recognize as pleasure. Pleasure is 
an essential aspect of motivational behavior in evolved organisms like 
mammals: it provides incentive to action. Mammals pursuit two essential 
biological purposes: their own survival and the preservation of the species. 
The achievement of these goals is based on the satisfaction of instincts, 
like hunger, thirst, reproduction, offspring care, which activate the reward 
system. Each stage of motivated behavior is associated with feelings of 
pleasure that drive the search for reward (Lang & Bradley, 2010). During 
the appetitive phase, characterized by a state of excitement that strengthens 
and supports searching for and approaching to the desired object, seeking 
behaviors remain flexible and generic; the behavior is driven by distal 
urges that are perceived through senses (smell, sight, hearing) and does not 
involve direct interactions with the object. During the consummation 
phase, rigid behavioral patterns prevail (Di Chiara, 2005).  
 
The brain systems of reward and motivation 
Reward and motivation mechanisms are mainly controlled by the limbic 
system, a set of cortical and subcortical areas involved in the genesis of the 
emotions, and in learning and memory. The reward brain centers were 
identified in 1954 by James Olds and Peter Milner. They observed that, 
when electrodes were placed in certain areas of the brain, rats would 
repeatedly self-stimulate these areas, often to the exclusion of all other 
activities, including eating. Further studies provided a more complete 
comprehension of the different neurotransmitter systems involved in the 
reward system: first, the dopamine (DA) system that controls the 
motivational boost to stimulus search, and the opioid system that mediates 
the processes of gratification arising from substance use. Equally important 
are the serotonergic system, that influences the activation of the set of  
 
mechanisms by which the different stimuli can induce motor and emotional 
responses, the glutamatergic system, that modulates the release of 
dopamine, and the GABAergic system, whose inhibitory activity is thought 
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to contribute to the development of tolerance and dependence. The DA 
system consists of a complex of neurons originated at the level of the A9 
and A10 nuclei of encephalic trunk. The A9 projects to the caudate and 
putamen, and the A10 to a complex structure called extended amygdala, 
including mesolimbic (nucleus accumbens - NAc, stria terminalis, 
olfactory tubercle) and mesocortical systems. In the opioid system, 
opioids, endorphins, enkephalins, and dynorphins are the main 
neurotransmitters. Thus, the reward circuit appears very complex and 
includes various brain regions, which are needed to characterize the 
experiences and to drive responses to reward activities such as food, sex, 
and social interactions. 
The mesolimbic pathway connects the ventral tegmental area (VTA) to the 
NAc, and operates like a switch of gratification, signaling to other brain 
centers if an activity is enjoyable, and how much. 
Higher the reward, greater the possibility of the body to store the action 
and to repeat it. This same neural circuitry is also active in learning and 
maintenance of addictive behaviors. In summary, there are three main 
pathways involved in appetitive behavior and drug seeking: 
- A circuit disrupting the reinforcing effects of a substance 
(gratification and stress) and integrating the rewarding or negative 
incentives associated to it. This is the so-called "extended amygdale" 
circuit that includes the central nucleus of amygdale, the bed nucleus of the 
stria terminalis and the NAc shell. 
- A circuit involved in relapse, including the prefrontal (PFC), 
anterior cingulate, orbitofrontal and prelimbic cortices, and basolateral 
amygdala. 
 
- A circuit involved in the search for substances ("compulsiveness"), 
including the NAc, ventral pallidum, thalamus, orbitofrontal and motor 
cortices. The NAc is thought to be the functional interface between 
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amygdala and striatum (ventral pallidum, ventral thalamus-cortex-striatum 
circuit). 
Other structures such as the hippocampus, that records the memories of 
experiences and DAergic and noradrenergic pathways of cortical areas are 
also involved (Koob & Le Moal, 2006; Gamberana, 2007). 
 
Dopamine, the rewarding hormone 
The DA reward pathways progress from the VTA to the nucleus 
accumbens, olfactory tubercle, ventral striatum and frontal cortex; the 
release of DA, the main chemical messenger of reward, is the final result 
of the action of each substance of abuse on this circuit. The release of DA 
from NAc shell is normally produced by a wide range of stimuli with a 
physiological, specific range for each subject regarding the amount of 
released DA and the level of response of mesolimbic DA receptors. 
Both neuroimaging studies and animal models have shown that the 
pleasure associated with the release of dopamine in the NAc is associated 
with incentive behaviors and provision of acquisition aspects of reward, 
experienced as urgency, or craving (Di Chiara & Imperato, 1988). Whereas 
natural rewards induce a rapid adaptive change after a few experiences 
(habituation), the novelty of the reward should have a major role in the 
initial response. The strong dopaminergic activation caused by natural 
reward stimuli decreases upon repetition (even after a single exposure) and 
learning (Bassareo et al., 1997); this rapid tendency of the system to 
undergo habituation explains why new stimuli are perceived as more 
attractive, suggesting a role of associative learning processes. DA release 
not only promotes research and approach in response to conditioned  
 
stimuli predictive of primary rewarding (incentive-motivational role), but 
also the acquisition of new conditioned stimuli facilitating associations 
between neutral and consumer stimuli (Pavlovian incentive learning) (Di 
Chiara, 2005). Thus, stimuli relevant to survival are marked with a burst of 
DA producing motivational incentive; the salient features of the context 
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are recorded, and pleasure is associated to stimuli. In this way, brain 
transforms a temporal contingency in a causal relation, and makes that 
context predictor of situations useful for survival. Differently from this 
basic mechanism, drug and/or behavior-induced reward is not affected by 
habituation, since each dose of the substance stimulates DA release.  
 
Molecular basis 
Important steps have been made in understanding the common molecular 
mechanisms and substrates shared by addiction, learning and memory (the 
immediate effect of a stimulus), but it remains unclear which substrates are 
involved in those stable brain changes leading to permanent behavioral 
changes that are typical of the advanced stages of addiction. Several 
transcription factors which regulate the expression or activity of specific 
genes have been investigated. Substances of abuse increase the 
concentration of dopamine in the NAc stimulating the D1 and D2 receptors 
coupled to G proteins. The stimulation of these receptors through the 
intracellular production of second messengers (cyclic adenosine 
monophosphate, inositol triphosphate, calcium) triggers the activation of a 
cascade of phosphorylating (kinase) enzymes that act on specific 
substrates. Phosphorylation can have immediate effects (acute behavioral 
effects) via voltage-gated channels, and long-term effects, mediated by 
proteins that act as transcription factors.  
The changes in signal transduction can induce long-term molecular 
neuroadaptations via transcription factors that modify gene  
 
expression; transcription factors (pCREB, pERK, pELK) trigger immediate 
early genes (FOS, June, etc.) which in turn activate the transcription of 
proteins important for neurotransmission (eg., preprodinorphin, a precursor 
of endogenous opioids). In parallel, the increase of intracellular calcium 
induces the release of neurotrophins: Brain-derived neurotrophic factor 
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(BDNF), nerve growth factor (NGF), Glial cell-derived neurotrophic factor 
(GDNF), Fibroblast Growth Factors (FGF), which act on various protein 
substrates through tyrosine kinase receptors.  
Repeated exposure to rewarding substances and/or behaviors changes the 
morphology and dendritic spine density in the NAc and hippocampus 
(Robinson & Kolb, 2004). These effects would be mediated by 
transcription factors. New connections are responsible for amplification of 
intercellular signals and overreaction of the brain to stimuli that recall 
drugs. 
 
Imaging studies 
During the recent years, advances in neuroimaging (fMRI, PET and 
SPECT) have made it possible to study changes in specific brain areas 
related to behavior; PET have evaluated the acute effects of substances on 
neurotransmitters such as DA, gamma-Aminobutyric acid (GABA) and 
opioids, whereas fMRI studies have investigated specific brain areas 
activity (PFC, amygdala, hippocampus, and NAc) at different stages of 
addiction (intoxication, craving and withdrawal). PET and SPECT studies 
showed minor striatal concentration of D2 receptors and blunted DA 
release and DA functionality in addicts (Schrantee et al., 2015). In 
addiction, DA dysfunction may imply a lessened sensitivity to natural 
rewarding stimuli, with substances intake becoming a privileged way to 
activate the reward circuits. Whereas the acute intake of substances causes 
an increase in DA transmission, chronic use would result in a reduced DA 
function which affects orbitofrontal cortex (OFC) and cingulate gyrus 
activities. These areas are involved in salience attribution and  
 
inhibitory control on dysfunctional behaviors; reduced DA transmission at 
these levels finally results in compulsive drug seeking. The same areas are 
hypoactive in withdrawal phase, but are activated when the subject takes 
the substance or engage in the behavior, is exposed to related stimuli, or 
experiences a strong desire for it.  
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 New theories of addictions 
The above drug and/or behavior-induced changes in the circuits of reward 
give rise to the clinical phenomena of tolerance, craving and relapse. Drug 
addiction, especially craving, would be characterized by functional 
impairment of fronto-striatal system. Chronic drug use causes a DA 
hypofunction in cortical areas that regulate cognitive functions, including 
those involved in controlling the compulsive search of the substance 
(Jentsch and Taylor, 1999). The corticofrontal regions control executive 
functions that include the ability to make decisions, to make inferences 
about possible consequences of actions, and to exert inhibitory control of 
behaviors; the prolonged substance use determines loss of cortical control 
over subcortical centers such as amygdala and the NAc involved 
themselves in control of impulses, learning and stress (Hyman & Malenka, 
2001). On these data, at present, some theories have been developed 
(Gamberana 2007). 
 
Abnormal Pavlovian incentive activation 
Drugs of abuse stimulate DA transmission in the shell of nucleus 
accumbens but, differently from primary rewarding stimuli, the release of 
DA is increased and prolonged, and it is not exposed to adaptive 
mechanisms that result in a progressive reduction of DA release. This loss 
of habituation causes an abnormal consolidation of  
 
the associations among the rewarding effects and the stimuli and/or 
contexts, assuming excessive incentive-motivational properties. Because of 
this abnormal learning incentive, stimuli associated with substances 
acquire disproportionate motivational salience. This pathway is also 
relevant for behavioral addictions. 
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This is a fundamental aspect of addiction: the abnormal compulsive ability 
of drug-conditioned stimuli to motivate behavior (craving). According to 
this hypothesis (Di Chiara et al., 2004), the abnormal motivation of drug 
addiction is the result of extremely strong associations between the 
substance and the associated Pavlovian stimuli that strengthen salience 
through the output of DA in the shell. DA release induced by new and 
unexpected primary reinforcement would produce an incentive status 
(euphoria) that would facilitate an instrumental behavior, the acquisition 
and expression of secondary reinforcement mechanisms, the re-
establishment of an instrumental response previously extinguished, and the 
consolidation of mnemonic traces of salient stimuli associated with 
emotional states. 
 
Allostatic states and counter adaptive processes among systems. 
Whereas the homeostatic systems of the body react to deviations of vital 
physiological parameters (pH, body temperature, blood sugar, oxygen 
tension) trying to keep within very narrow limits compared to the base 
value, the allostasis tends to reach stability through change. Allostatic load 
involves the price the organism must pay for adapting to an adverse 
situation (both psychological or physical), reflecting too much demand on 
the activity of regulatory systems (McEwen, 1998). When the demand of 
new adaptations becomes excessive, or prolonged over time, the ability to 
adapt and to reach new set-points of homeostasis may fail, leading to the 
development of dysfunction and diseases (McEwen, 2005). It is 
hypothesized that changes in the brain systems associated with the 
development of affective and motivational states can be a source of 
potential allostatic changes that support the transition from use to abuse  
 
(Koob & Le Moal, 2001). Affective states, pleasant or unpleasant, are 
normally modulated by central mechanisms that progressively reduce their 
intensity (Solomon & Corbit, 1974). Allostatic load from negative 
affective states may dysregulate reward neurocircuitry within the extended 
amygdala, resulting in diminished sensitivity to reward and augmented 
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sensitivity to aversive states. Thus, an allostatic state can be defined as a 
state of chronic deviation of the regulatory systems from their normal 
activities (homeostasis) with establishment of a new set point (Koob & Le 
Moal, 2001). As natural rewards lose their reinforcing value, and negative 
affects increase under stress conditions, this alteration in reward threshold 
may cause increased use of substances or repetition of rewarding 
behaviors, aimed to maintain a hedonic equilibrium. Drug and behavioral 
addictions may involve a modification in reward set point, reflecting  an 
allostatic, rather than a homeostatic, adaptation. Whereas reward 
neurotransmitters (DA, opioids) usually have a limited capacity to 
maintain reward function within homeostatic range, drug intake can extend 
this capacity, but also leads to neuroadaptation within the DA and opioid 
peptide systems. The neuroadaptation within the system consists of cellular 
and/or molecular changes inside the reward circuit that finally reduce its 
function. These mechanisms of neuroadaptation can completely 
counterbalance the effects of substances, leading to tolerance. Abrupt 
discontinuation of the substance causes the emergence of symptoms 
(withdrawal syndrome) that are expression of these adaptive processes. 
According to this view, in addiction a dysregulation of reward and 
antireward systems gradually increases, causing the compulsive use of 
substances (Koob & Le Moal, 2001). 
In animal models of transition to addiction, the reduction of reward 
precedes and is strongly correlated with drug-intake increase. It has been 
shown that, whereas repeated dosing of psychostimulants facilitates DA 
and glutamatergic transmission in the NAc (Ungless et al., 2001), chronic 
administration is followed by a reduction of the  
 
transmission (Kalivas et al., 2003), causing the hypofunction of the reward 
system via neuroadaptive changes in opioid receptors in the NAc (Shaw-
Lutchman et al., 2002), and in GABAergic transmission (Roberto et al., 
2004). Imaging studies in addicts during withdrawal provide similar results 
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to those of animal models: reduction of D2 receptors (reflecting a 
dopaminergic hypofunction) and hypoactivity of the OFC infralimbic 
system (Wilson & Sayette, 2015). It has been suggested that the reduction 
of the neurotransmitter function of reward significantly contributes to acute 
negative emotional states associated with abstinence from substances and 
could trigger long-term biochemical changes that contribute to the 
syndrome of protracted withdrawal and vulnerability to relapse.  
The neurochemical systems involved in stress modulation may be involved 
in the attempt to restore the normal reward functions, overcoming the 
deterioration caused by the chronic presence of the drug. The 
hypothalamic-pituitary-adrenal axis and stress circuits, both mediated by 
CRF, are disrupted by the chronic administration of substances of abuse, 
resulting in increases of adrenocorticotropic hormone, cortisone, and CRF 
levels (Koob & Le Moal, 2005; Kreek & Koob, 1998), in norepinephrine 
(NE) release in the roof nucleus of stria terminalis, and in the reduction of 
neuropeptide Y release (Olive et al., 2002). 
Anti-reward brain systems modulated by CRF, NE, dynorphin, inducing 
aversive, stress-like states, are recruited in the processes of dependence 
and withdrawal (Aston-Jones et al., 1999; Koob, 2003; Nestler, 2001), 
concomitant with the reduction of reward function in the motivational 
circuits of the ventral layer of the extended amygdala. This combination 
provides a powerful negative reinforcement that contributes to the 
compulsive urge to abuse.  Conceptualizing addiction as a simple 
disruption of those brain homeostatic mechanisms that regulate emotional 
states is not sufficient to explain the key elements of addiction: it worsens 
over time, is subject to significant environmental influences, and it leaves a 
residual neuroadaptive trace which facilitates rapid relapses even after 
years of detoxification and abstinence. 
 
 
Sensitization and addiction 
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The Incentive-Sensitization Theory of Addiction (Robinson & Berridge, 
1993) postulates that repeated exposure to substances would result in a 
hypersensitivity of brain circuits (NAc and ventral striatum) that mediate 
the incentive motivation function. Sensitization of these neural systems by 
drugs results in a pathological enhancement of the incentive salience 
attributed to the act of drug taking, with associative learning mechanisms 
directing the focus of incentive salience to specific targets associated with 
substances and drug-related stimuli. The sensitization process involves 
neuroadaptive changes both in the neurotransmitter systems (serotonin, 
glutamate, DA, NE, and GABA), and in synaptic plasticity (NAc, cortex), 
with changes in length, density, and type of dendritic spines. Moreover, the 
neuroadaptations underlying sensitization are long-lasting and, in some 
cases, permanent; this persistence of sensitization-related neuroadaptation 
is thought to make addicts hypersensitive to substances/behaviors and to 
drug-related stimuli, even after years of abstinence, precipitating relapses. 
According to this conceptualization of incentive motivation, salience 
attribution is a process that is activated normally in concurrence with 
reward and associative learning in the formation of new incentives. Thus, 
incentive motivation should involve three distinct processes acting 
together: pleasure, incentive salience, and associative learning, all 
subtended by distinct, although interacting, neurobiological systems.  
 
Drug addiction as a maladaptive habit 
According to this hypothesis, drug addiction would be the final step of a 
continuum starting from the initial use of a substance, voluntarily assumed 
for several incentive effects, through a gradual loss of control on behavior  
 
that progressively becomes a habit and, finally, a "compulsion". The 
evidences in support of this hypothesis are heterogeneous, and in general 
indicate the dorsal striatum, specifically the dorsolateral part, as a major 
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influencer of this progression:  a goal-directed phase driven by an explicit 
memory is gradually transformed in a habitual behavior driven by an 
implicit memory. The maintenance of instrumental behavior in these 
conditions reveals the degree of control that the stimulus-response 
mechanism has acquired on the behavior. The transition from voluntary 
actions (mainly controlled by their consequences) to habits (automatic 
behavioral responses) in the substance-seeking behavior reflects the switch 
from a cortical (prefrontal) to a subcortical control involving striatal areas. 
This hypothesis is partly supported by neuroimaging studies in samples of 
addicts, showing the reduction of the prefrontal and orbitofrontal cortices 
activity (Goldstein and Volkow, 2002). 
 
Towards an integration of the different paradigms 
As previously reported, substances of abuse and addictive behaviors 
determine molecular alterations induced by stimulation of DA receptors 
and changes in plasticity promoted by the expression of new genes (Berke 
and Hyman, 2000). Furthermore, is reasonably acknowledged that 
addiction, craving, withdrawal, and tolerance can recognize different 
neurobiological mechanisms. Actually, it is thought that tolerance and 
withdrawal are not closely related with persistent drug-induced molecular 
changes, since they disappear within a few days or weeks after intake. 
Therefore, the brain areas involved in withdrawal are different from those 
implicated in addiction. Many of the clinical symptoms in withdrawal are 
due to neural activation of the locus coeruleus, resulting in release of NE, 
whereas the reduction of DA transmission in the striatum is involved in 
motivational disorders (anhedonia) in withdrawal and implicated in 
determining individual differences in vulnerability to addiction and relapse 
(Melis et al, 2005). The primary, maybe constitutional, weakness of DA 
transmission is indicative of more rewarding effects associated with drugs 
of abuse, a feature related to a heightened vulnerability to addiction; the 
same feature may account for the higher risk for relapses in abstinent 
and/or detoxified individuals (Kalivas & Volkow, 2005). All substances of 
abuse, although belonging to different pharmacological classes, have in 
common the ability to exploit physiological mechanisms of adaptive 
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responsiveness of DA in the nucleus accumbens shell, via the abnormal 
strengthening of stimulus-substance associations; these mechanisms are 
central both in the transition from habit to addiction and in recovery and 
relapse processes. 
The repeated exposure to the substance entails a reduction of DA 
transmission, which acts as a powerful motivation for maintenance and 
relapse. Neuroadaptive changes in subcortical DA transmission derived 
from chronic exposure to the substance may secondarily impact the 
functionality of those prefrontal-striatal circuits responsible for the loss of 
control on behavior (impulsiveness), and the impairment of decision-
making that underlie addiction.  
However, within a merely neurobiological framework, the increase of DA 
concentration in the NAc induced by substances cannot explain all the 
phenomena connected with drug addiction, since each step in the process 
of addiction could be controlled by different neuroadaptive and 
neurotransmitter changes in different brain.  
 
Psychological aspects 
Psychoactive substances and addictive behaviors have attracted substantial 
interest in the medical fields of research, and therefore emphasis was put to 
alleged predisposing biological factors and to the peculiar pharmacological 
profiles of each class of drugs. Another line of research has evaluated the 
emotional, cognitive and motivational processes, decision-making, and 
social influences involved in addiction (Ravenna, 1997). Beyond the 
biological framework, the complex phenomena of addiction and 
dependence need to be analyzed also at a psychological level. Cognitive  
 
theories propose that addiction processes and the perceived effects of the 
different substances are strongly influenced by cognitive-motivational 
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factors such as attitudes, expectations and beliefs. These beliefs, usually 
learned within social and relational contexts, provide addicts a range of 
explanations for interpreting and justify their consumption behavior, where 
more positive beliefs lead to a greater likelihood that people can begin or 
continue drug-intake. 
Systemic approach.  
This approach focuses on systems in which the addicted is involved, 
primarily the family, focusing on relational and contextual variables more 
than on intrapsychic factors. Studies carried out in the second half of the 
„70s by US family therapists have shown that addicts, when compared with 
healthy controls, are not only drug-dependent, but they also show high 
levels of dependence from the family unit. In families of addicts a 
subversion of "traditional hierarchies” was found; the father was absent 
and emotionally distant, whereas the mother was overinvolved, indulgent 
and often symbiotic. In many cases, the child-mother-grandmother alliance 
hindered the parental couple. Drug addiction, viewed as a family symptom, 
was functional to maintain the stability of the couple, playing a 
homeostatic role that diverted attention from marriage conflicts by 
allowing the couple to regain solidarity needed to deal with the addiction 
problems of the child. On the other hand, the addicted child, recognized as 
a “patient” affected by a disease, was placed in the center of family. 
Stanton (1979) introduced the concept of "pseudo-individuation" to explain 
the prolonged dependence between the addict and his parents; drugs and 
other transgressive and/or deviant behaviors are means by which the child 
attempts to separate him/herself from parents, but the drug-intake makes 
him/her increasingly dependent from the family that provide support, help, 
and money. The family is so "glued", becoming unable to cope with 
separation anxieties. According to Cirillo and colleagues (1996), what lies 
beneath drug addiction is maternal neglect that produces pathological 
attachment styles in the  
 
child. According to this perspective, addiction is not the result of a mere 
hyper-maternal involvement along with a distant and marginal father, but 
the outcome of an intergenerational transmission of deprivation, neglect, 
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and traumatic experiences not enough elaborated. Within this framework, 
the families of the addicts may be characterized more by a peculiar 
"internal quality", a blend of intense, long-lasting, not elaborated traumatic 
experiences, antecedent the onset of addiction, more than by impairment in 
social affiliation or in structural cohesion. 
 
Psychosocial perspective.  
The difficulty to deal with the demands and pressures from the 
environment can lead adolescents to identity problems, anxiety, and social 
isolation. Attempting to prevent or counteract these painful psychic 
experiences, involving intolerable anxieties of failure and fragmentation of 
the self, adolescents may look for alternative forms of adaptation, choosing 
the “addict” identity (Ravenna, 1993). Such perspective integrates the 
stress-coping model (the occurrence of stressful events increases the 
likelihood drug use) with the adjustment theories (in poor-skilled subjects, 
substance abuse and addictive behaviors are way to cope with negative 
emotional states and severe and prolonged psychological discomfort). 
Within the modern psychodynamic framework, addiction is not more 
explained in terms of impulse control and the prevalence of destructive 
instincts, but rather focusing on identification processes and object 
relations that characterize identity formation. 
Olievenstein (1982) argues that the future addict come into adolescence 
with a sense of incompleteness derived from the failure of the mirror stage 
in the first two years of life. The failure of the mother‟s ability to view the 
child as a separate individual, and to recognize his/her child‟s needs, has  
 
significant repercussions on the construction of a stable identity. The 
mirror is broken, and the result is a deep sense of incompleteness, lessened 
by the drug which provides a temporary restoration of the whole person 
through an illusory fusional dynamic with the mother. According to 
20       SCALA, MUSCATELLO et al. 
   
Bergeret (2001) the addict suffered early in life from repeated frustrations 
in the primitive relationships, so desires are transformed into simple needs 
which can be satisfied through acting-out behaviors rather than through 
mentalization, imagination, and symbolization. Consequently, no symbolic 
acts can counterweigh the immediate pleasure and the feeling of triumph 
provided by the satisfaction of needs. These needs tend to rule out the 
presence of another person and have strong aggressive components. There 
is a difficulty of integration in childhood and adolescence that remain 
suspended in a sort of "pseudo-ending latency". The author distinguishes 
three types of addicts: a neurotic structure (with self-injurious and 
masochist behaviors), a psychotic structure (taking drugs to contrast or 
justify the overflow of their imaginary), and depressive structure 
(undecided, fluctuating and dependent subjects). Kohut (1971) has pointed 
out the possibility that serious and traumatic deficiencies in the mother-
child relationship may cause serious identity disorders in the child. The 
child removes the disillusion towards the mother by maintaining the first 
idealized image of the mother-child fusional couple, to relieve the pain of 
trauma. This gives rise to a weak Ego unable to tolerate frustration, and 
dependent on a parent (usually the mother) experienced as omnipotent but 
unable to relieve the pain. The drug as an inanimate, controllable object, 
moves away the sense of inadequacy and allows the addict to face the 
reality of growth, with the associated inevitable frustrations. Cancrini 
(1984), using a psychiatric clinical approach based on the study of 
symptoms and observable behaviors, considers drug abuse as an attempt to 
deal with levels of pain perceived as intolerable. Addictions are 
heterogeneous conditions sharing the common feature of substance use as 
a way to deal with discomfort.  The author classifies them into four types 
according to the role played by endogenous and exogenous causes on the 
individuals‟ psychological organization, and to family organization and 
communication styles. Type A dependence includes adjustment reactions,  
 
characterized by a close association with traumatic events and addictive 
behavior, which often develops in the absence of interpersonal 
relationships perceived as reliable and safe. Type B dependence pertains to 
the neurotic area; the subject deals with problems of construction of the 
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self during adolescence, and that can be subtended by psychiatric 
conditions such as anxiety, mood changes, uncertainty, boredom 
proneness, dissatisfaction, and dramatization. These are individuals are 
accustomed to engage in parental conflict and to seek attention and 
affection in the dramatization of their discomfort. Family dynamics in this 
case are often characterized by a strong collusion between one parent and 
the child, with the parent (usually the mother) attempting to hide the 
child‟s deviant behaviors, making the educational process ineffective. 
Type C group includes dependence within the context of limit states and 
psychosis in which primitive defense mechanisms (split, denial, projective 
identification) prevail, leading to a diminished ability to experience states 
of pleasure and comfort. The predisposing factor seems to be the 
incomplete personality formation, characterized by a strong immaturity 
and by the inability to form stable emotional bonds. The family system 
shows a chaotic style in defining roles and borders which remain unstable 
and fluctuating; moreover, the communication is paradoxical, 
contradictory, and unclear. In these cases, the drug can briefly alleviate the 
discomfort, providing a state of inner freedom and rediscovered unity. 
Finally, Type D dependence refers to antisocial areas, and reflects a lack of 
social integration and disruptions in early childhood development. 
Individuals tend to express the conflicts through acting-out and take the 
drug in a callous, detached way, as a challenge to society, within the 
context of deviant and violent environments that strengthen such conducts. 
 
Evolutionary-relational model.  
 
 
A deep understanding of addictive behaviors cannot ignore the individual 
as a whole, his/her personality traits, and his/her relational history from the 
earliest years of life. Recent studies have highlighted the role of neglect, 
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particularly frequent in the family history of addicts, and its possible 
repercussions on the development of those cognitive and metacognitive 
skills involved in emotional regulation and necessary for adaptation to 
social demands. In healthy development, the special attention provided by 
the caregiver to the child's emotions is expressed through an affective 
syntonization process (Stern et al, 1987) that makes possible to share 
positive emotional states, manifested by the child through play and other 
activities, and that will form the foundation of future affective and 
relational models. The caregiver‟s abilities to stay emotionally in tune with 
the child, to correctly interpret his/her emotional displays, and to promptly 
adapt behavior accordingly, promote the healthy emotional and cognitive 
development of the child, forming a relational world in which the child can 
experience him/herself as a living being who feels, thinks, wants. 
Normally, the development progresses from a mere sensory experience of 
reality to a more complex construction of the inner and external world; the 
essential stage of this process is the progressive emergence of awareness 
and mentalization. The caregiver‟s emotional skills help the child to focus 
on his/her inner emotional experiences, giving them a form: so, emotions 
become meaningful and manageable (Fonagy & Target, 2001). 
Contrarily, the emotionally neglected child, who is not “mirrored” by the 
caregiver, develops a reduced ability to represent his/her own and others' 
mental states along with the frequent occurrence of developmental 
disorders and, in adulthood, may present psychopathological conditions 
characterized by an inner dimension of affective and cognitive emptiness, 
which can finally lead to addictive behaviors as a coping strategy (Caretti 
& Di Cesare, 2005). According to this model, mentalizing deficits are 
related with pathological dissociative mechanisms that are structured 
during childhood in response to early relational failures. Dissociation, as a 
defense mechanism, is a normal function of mind which excludes painful 
emotions and sensations from consciousness, a locking mechanism 
 
that protects the Ego through the active inhibition of intolerable 
information and builds a better, although false, reality. The relief arising 
from this temporary shelter is not pathological, but its excessive recurrence 
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increases reality distortions, and affects the sense of self and significant 
relationships, promoting the loss of contact with the reality in favor of 
compulsive, impulsive, and addictive behaviors. Addiction would 
represent a dissociative response, able to anesthetize the discomfort 
generated by the emergence of traumatic memories and emotions, and of 
splitted states of the Self, under stress conditions. Abuse, emotional neglect 
and attachment disorders in childhood may increase the psychological 
vulnerability towards addictive behaviors, in which drug-intake and 
addictive behaviors promote the achievement of dissociated state of mind. 
Although dissociation as a defense is central in maintaining personal 
continuity, consistency and integrity of the sense of Self, avoiding the 
traumatic dissolution (Bromberg, 2001), in addictive behaviors dissociative 
withdrawal weakens affects regulation, and increases the compulsive use 
of psychoactive substances, intensifying pleasant sensations, and reducing 
the intensity of dysphoric states. Within the context of this model, craving 
seems to be the core feature in various forms of pathological addiction. 
Defined as a strong, uncontrollable desire toward a reinforcing stimulus 
(Janiri et al., 2006), or as a conditioned appetitive motivational state 
(Franken, 2003), craving may occur in relation to different objects and/or 
behaviors, and is activated in the presence of environmental stimuli that 
recall the drug, although it can occur in response to stressful events or 
aversive emotional states; dissociated mental states contribute to 
strengthen craving mechanisms. 
As mentioned above, if we consider addiction as a disorder based on 
dissociative defense mechanisms resulting from traumatic childhood 
experiences, it is easy to understand the role of pre-existing 
psychopathological conditions, beyond the rewarding properties of 
substances. According to the self-medication hypothesis formulated 
 
by Khantzian (2003), addiction is an attempt of recovering from aversive 
states of mind and traumatic memories. In line with these considerations, 
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McDougall (2003) argues that, although the addict may suffer his/her 
slavery from psychotropic drugs or compulsive behaviors, the object of 
dependence is experienced unconsciously as "essentially good" because it 
brings wellness and, in extreme cases, it can be considered as the only 
thing that makes life meaningful. Given that craving is reinforced both by 
rewarding and positive sensations derived from drug effects, and by 
negative and painful abstinence symptoms, it becomes enough clear that 
therapeutic approaches based only on rehabilitation and/or pharmacology 
are expected to be almost ineffective. If the psychopathological and 
emotional aspects of addiction are not adequately addressed and 
mentalized, they will always remain in the background, contributing to 
reduce self-care and abstinence, affecting the detoxification process, and 
facilitating craving and relapses.  
 
Conclusions 
Addiction, whether to substances or pathological behaviors, is an 
extremely complex phenomenon, that can be considered the outcome of 
different pathways, derived from the interaction of biological, 
psychological and social risk factors and vulnerabilities. The contribution 
of each factor can be very different from case to case, explaining the 
extreme individual variability in terms of clinical expression, 
susceptibility, and response to treatment. During the recent years, the study 
of addictions has rapidly expanded, and this research field has become one 
of the most challenging and complex. Not differently from other 
psychiatric disorders, transition to addiction is a multistep process 
depending on the interaction between a vulnerable individual, in a 
biopsychosocial sense, and a stimulus (substances of abuse, behaviors) 
which is not pathogenic in the general population. Psychiatrists and 
psychologists struggle with a large and differentiated framework of 
disorders: compulsive shopping, technological dependencies, new drugs of 
abuse,  
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emotional and sexual addictions, exercise and work addiction. Many of 
them have been focused by research and systematic studies, diagnostic 
criteria and guidelines. A further reason to investigate these forms of 
psychopathology, which have a significant impact in everyday life, comes 
from their ability to express and represent, more effectively than other 
psychiatric disorders, the actual discomfort of civilization. The rapid and 
profound changes in social life, family structure and organization, 
consumer styles, cultural patterns and the management of leisure tend to 
modify the cognitive structure and the regulation of affective states, finally 
promoting the pathway to addiction. Therefore, research focused on drug 
and behavioral addictions should expand the knowledge of the multistep 
process of pathogenesis, with the final aim to find appropriate 
multidisciplinary models for an optimal prevention and treatment of these 
emergent, multifaceted conditions 
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